Targeting Nrf2-HMOX1 to Reverse Cisplatin Resistance
In a groundbreaking study poised to shift the paradigm of lung cancer treatment, researchers have uncovered a pivotal pathway that...
Nathaniel Bowman is a Scienmag editorial specialist profile for Precision Oncology coverage.
In a groundbreaking study poised to shift the paradigm of lung cancer treatment, researchers have uncovered a pivotal pathway that...
In a groundbreaking study published recently in Cell Death Discovery, researchers have unveiled a novel mechanism by which a truncated...
In a groundbreaking study poised to redefine our understanding of glioblastoma biology, researchers have uncovered a paradoxical role of Gasdermin...
A groundbreaking new study reveals crucial immune system alterations in cancer patients undergoing treatment with immune checkpoint inhibitors, potentially paving...
In a counterintuitive twist to longstanding concerns about cognitive health following cancer treatment, a groundbreaking cohort study has revealed that...
A groundbreaking clinical trial led by researchers at University College London (UCL) has unveiled the potential to fundamentally alter the...
In a groundbreaking study poised to reshape cancer therapeutics, researchers led by City of Hope have unveiled unprecedented insights into...
In a groundbreaking advance that could redefine treatment paradigms for pediatric acute myeloid leukemia (AML), scientists from St. Jude Children’s...
Esophageal cancer remains one of the most lethal malignancies worldwide, primarily due to its aggressive nature and the challenges associated...
In recent years, the landscape of cancer treatment has been dramatically transformed by the advent of immune checkpoint inhibitors (ICIs),...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine